Literature DB >> 17983932

Endocrine complications of hematopoietic stem cell transplantation.

Wassim Chemaitilly1, Charles A Sklar.   

Abstract

Advances in hematopoietic stem cell transplantation (HSCT) have resulted in broader indications for this therapeutic modality in both malignant diseases and nonmalignant conditions. This article focuses on the late endocrine abnormalities that are most commonly observed following successful HSCT, with a special emphasis on pediatric HSCT recipients, for whom long-term follow-up data are increasingly available.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17983932     DOI： 10.1016/j.ecl.2007.07.002

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  8 in total

Review 1.  Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up.

Authors:  Smita Bhatia
Journal:  Expert Rev Hematol       Date:  2011-08       Impact factor: 2.929

2.  Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease.

Authors:  Saro H Armenian; Can-Lan Sun; Tabitha Vase; Kirsten K Ness; Emily Blum; Liton Francisco; Kalyanasundaram Venkataraman; Raynald Samoa; F Lennie Wong; Stephen J Forman; Smita Bhatia
Journal:  Blood       Date:  2012-10-03       Impact factor: 22.113

3.  Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS).

Authors:  Saro H Armenian; Can-Lan Sun; Toana Kawashima; Mukta Arora; Wendy Leisenring; Charles A Sklar; K Scott Baker; Liton Francisco; Jennifer Berano Teh; George Mills; F Lennie Wong; Joseph Rosenthal; Lisa R Diller; Melissa M Hudson; Kevin C Oeffinger; Stephen J Forman; Leslie L Robison; Smita Bhatia
Journal:  Blood       Date:  2011-06-07       Impact factor: 22.113

4.  Ethnic differences in chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.

Authors:  Saro H Armenian; Can-Lan Sun; Jennifer Berano Teh; Mukta Arora; K Scott Baker; Liton Francisco; Stephen J Forman; Smita Bhatia
Journal:  Cancer       Date:  2010-09-01       Impact factor: 6.860

5.  Late effects of total body irradiation and hematopoietic stem cell transplant in children under 3 years of age.

Authors:  Jean M Mulcahy Levy; Tiffany Tello; Roger Giller; Greta Wilkening; Ralph Quinones; Amy K Keating; Arthur K Liu
Journal:  Pediatr Blood Cancer       Date:  2012-07-27       Impact factor: 3.167

Review 6.  Cardiovascular disease in survivors of hematopoietic cell transplantation.

Authors:  Saro H Armenian; Eric J Chow
Journal:  Cancer       Date:  2013-10-25       Impact factor: 6.860

7.  Endocrine complications after hematopoietic stem cell transplantation during childhood and adolescence.

Authors:  Min Ho Jung; Kyoung Soon Cho; Jae Wook Lee; Nak Gyun Chung; Bin Cho; Byung Kyu Suh; Hack Ki Kim; Byung Churl Lee
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

8.  Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors.

Authors:  P Anur; D N Friedman; C Sklar; K Oeffinger; M Castiel; J Kearney; B Singh; S E Prockop; N A Kernan; A Scaradavou; R Kobos; K Curran; J Ruggiero; N Zakak; R J O'Reilly; F Boulad
Journal:  Bone Marrow Transplant       Date:  2016-03-21       Impact factor: 5.483
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.